NCT00816192

Brief Summary

There is no study comparing safety/efficacy of externally vs internally cooled tip catheters in patients undergoing ablation for paroxysmal atrial fibrillation (pAF). The primary objective is to compare safety and efficacy of externally irrigated-tip catheter versus internally irrigated-tip catheter in achieving long term electrical isolation (EI) of pulmonary veins (PV) in paroxysmalatrial fibrillation (pAF).

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
86

participants targeted

Target at P25-P50 for not_applicable atrial-fibrillation

Timeline
Completed

Started Dec 2008

Geographic Reach
1 country

2 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2008

Completed
29 days until next milestone

First Submitted

Initial submission to the registry

December 30, 2008

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 31, 2008

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2011

Completed
Last Updated

July 27, 2012

Status Verified

July 1, 2012

Enrollment Period

2.2 years

First QC Date

December 30, 2008

Last Update Submit

July 26, 2012

Conditions

Keywords

FAAtrial fibrillationCatheterAblationRF

Outcome Measures

Primary Outcomes (1)

  • RF duration (in minutes) to succeed in PVs isolation

    Along intervention

Secondary Outcomes (2)

  • The absence of pAF

    at 3 and 6 months off AAD

  • The determination of serious adverse events (Complications resulting from vascular access will not be included in this category).

    During 6 months

Study Arms (2)

1

ACTIVE COMPARATOR

The externally irrigated-tip catheter is an "open system" in which saline is continuously infused and empties into the blood pool. For the externally irrigated-tip catheter, RF energy delivery settings were: power ≤ 35 watts and temperature ≤ 43°C with a variable flow-rate to obtain a temperature around 40°C.

Procedure: Long-term electrical isolation of pulmonary veins

2

EXPERIMENTAL

For the internally irrigated tip catheter (reference catheter), radiofrequency (RF) energy delivery settings will be: power ≤ 35 watts, temperature ≤ 47◦C and a fixed flow rate of 0.6 ml/s. The advantage of the Chili thermo-cooled tip system is that no saline solution leaves the catheter system and flows into the patient.

Procedure: Long-term electrical isolation of pulmonary veins

Interventions

All AAD except amiodarone will be stopped five half-lives before the procedure. Our ablation protocol will require 3 catheters. A quadripolar stearable mapping catheter was inserted into the coronary sinus, a decapolar circular mapping catheter was placed at the antrum of the PV after transeptal puncture to help for electrical disconnection of all four PV with the randomized ablation catheter. After transseptal access, an intravenous bolus of heparin was administered and repeated 3 to 4 hours later. Atrial burst will then be used to induce AF. With the ablation catheter positioned proximal to Lasso catheter on the atrial aspect of PV ostium, isolation will be performed.

12

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults (≥18 years old)
  • Drug refractory paroxysmal AF with episods lasting \<24hours
  • Follow-up possible at one of the 2 institutions performing the study
  • Oral agreement of the patient after reading the document of information

You may not qualify if:

  • Pregnancy
  • Psychiatric troubles not stabilized
  • Contraindication to undergo AF ablation
  • Previous attempt at AF ablation
  • Cardioversion for AF
  • No oral agreement of the patient for the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University Hospital

Bordeaux, 33064, France

Location

Clinique Pasteur

Toulouse, 31076, France

Location

MeSH Terms

Conditions

Atrial Fibrillation

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Michel HAÏSSAGUERRE, Pr

    University Hospital, Bordeaux

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 30, 2008

First Posted

December 31, 2008

Study Start

December 1, 2008

Primary Completion

March 1, 2011

Study Completion

March 1, 2011

Last Updated

July 27, 2012

Record last verified: 2012-07

Locations